Clinical Trials Directory

Trials / Completed

CompletedNCT06057883

Effects Of A Probiotic Formulation On Stress and Skin Health in Younger Adult Females

Effects of Probiotics Formulation on Stress and Skin Health in Younger Adult Females: A Holistic Approach to Skin Health, an Open-Label Proof-of-Concept Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Lallemand Health Solutions · Industry
Sex
Female
Age
30 Years – 45 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to test to efficacy of a probiotic blend on stress and skin appearance in young females. It is hypothesized that those taking the probiotic blend will have decreased levels of perceived stress and this will be reflected positively on their skin appearance.

Detailed description

The goal of this open-label clinical trial is to evaluate the potential beneficial effects of a probiotic formulation on mental wellbeing and skin appearance in healthy young adult females in line with the holistic approach context and beauty from within principle. The main questions it aims to answer are related to: * Probiotics effects on stress. * Probiotics effects on sleep quality. * Probiotics effects on skin appearance (fine lines and skin tone) and parameters (hydration and firmness) Participants will be recruited and, if consenting and eligible, will be provided with the probiotic capsules and instructed to ingest one capsule daily, preferably in the evening for 56 consecutive days. In-person visits will take place at baseline, mid-intervention (Day 28), and end of intervention (Day 56) to carry out assessment activities at Cosderma site. Researchers will compare the outcome assessment measures after the probiotic ingestion to baseline values to highlight any significant effects or trends.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticA blend of two probiotic strains. Participants will take 1 capsule daily at 3 billion Colony Forming Units (CFUs)

Timeline

Start date
2023-09-27
Primary completion
2023-11-24
Completion
2023-11-24
First posted
2023-09-28
Last updated
2024-02-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06057883. Inclusion in this directory is not an endorsement.